Clinical Trial


A Study of GW685698X 100mcg Administered Once Daily Either in the Morning or the Evening and GW685698X 250mcg Administered Once Daily in the Evening Via DISKHALER for 28 Days in Subjects With Persistent Bronchial Asthma.


Brief description

The purpose of this study is to compare the efficacy and safety of GW685698X 100mcg once daily either in the morning or the evening and GW685698X 250mcg administered once daily in the evening via DISKHALER for 28 days in subjects with persistent bronchial asthma.

Keywords

  •   Asthma

Sponsored By

GlaxoSmithKline

Unique Study ID

NCT01499446

Investigators and Research Sites Near You - Found( 3 )

Laura B. Jardim, MD, PhD

Hospital de Clinicas de Porto Alegre
90035-903, Porto Alegre, Rio Grande Do Sul, Brazil
Distance from Current Trial is 0 miles

No Investigator Listed

Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande Do Sul, Brazil
Distance from Current Trial is 0 miles

No Investigator Listed

Hospital de Clinicas de Porto Alegre
Porto Alegre, Rio Grande Do Sul, Brazil
Distance from Current Trial is 0 miles
View All